Carlsmed, Inc. (CARL) vs Editas Medicine, Inc. (EDIT)
A side-by-side comparison of Carlsmed, Inc. and Editas Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CARL
Carlsmed, Inc.
$14.91HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
EDIT
Editas Medicine, Inc.
$2.83HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — CARL vs EDIT
growth of $100 · dividends reinvested · last 1yCARL +5.5% (+5.5%/yr)EDIT -17.0% (-17.0%/yr)CARL compounded faster over this window
CARL EDIT
CARL vs EDIT: by the numbers
- •EDIT is the larger company ($434M vs $405M market cap).
- •Both run net losses; CARL's is the smaller (-57.42% vs -157.32% net margin).
Metrics side by side
Valuation
| Metric | CARL | EDIT |
|---|---|---|
| P/S ratio | 6.40 | 9.22 |
| P/B ratio | 4.81 | 4.12 |
Profitability
| Metric | CARL | EDIT |
|---|---|---|
| Gross margin | 76.63% | 100.00% |
| Operating margin | -61.09% | -245.15% |
| Net margin | -57.42% | -157.32% |
| ROE | -43.14% | -70.24% |
| ROIC | -36.54% | -48.61% |
Growth (annualized)
| Metric | CARL | EDIT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -10.34% |
| Total return CAGR (5Y) | N/A | -40.76% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.